|
HARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.230400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.621630E-01 |
| Normal-vs-Stage2 |
3.822700E-04 |
| Normal-vs-Stage3 |
2.076400E-01 |
| Normal-vs-Stage4 |
3.098000E-01 |
| Stage1-vs-Stage2 |
2.855200E-03 |
| Stage1-vs-Stage3 |
9.982000E-01 |
| Stage1-vs-Stage4 |
9.330800E-01 |
| Stage2-vs-Stage3 |
2.556400E-03 |
| Stage2-vs-Stage4 |
1.967800E-02 |
| Stage3-vs-Stage4 |
9.362400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.914400E-02 |
| Normal-vs-AfricanAmerican |
3.869000E-01 |
| Normal-vs-Asian |
7.858400E-03 |
| Caucasian-vs-AfricanAmerican |
7.914000E-01 |
| Caucasian-vs-Asian |
1.286360E-01 |
| AfricanAmerican-vs-Asian |
1.943780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.465810E-02 |
| Normal-vs-Female |
7.525600E-02 |
| Male-vs-Female |
1.894380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.153400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.026300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.741600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.656000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.809040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.411400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.058200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.237000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.551200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.320400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.084100E-02 |
| Classical-VS-Follicular |
9.334200E-01 |
| Classical-VS-Other |
4.300200E-01 |
| Classical-VS-Normal |
1.152080E-02 |
| Tall-VS-Follicular |
5.714200E-02 |
| Tall-VS-Other |
8.184000E-01 |
| Tall-VS-Normal |
7.835600E-01 |
| Follicular-VS-Other |
5.092800E-01 |
| Follicular-VS-Normal |
6.173700E-02 |
| Other-VS-Normal |
9.305000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.835700E-03 |
| Normal-vs-N1 |
9.427200E-01 |
| N0-vs-N1 |
5.871800E-02 |
|
|
